NCT00611351 2023-10-23Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerUniversity of NebraskaPhase 2 Completed5 enrolled 10 charts
NCT00445744 2018-01-02Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic SyndromeFred Hutchinson Cancer CenterPhase NA Completed52 enrolled 7 charts